中文 | English
Return
Total: 14 , 1/2
Show Home Prev Next End page: GO
Author:(Javier TORRES)

1.Severe Weakness of Hip Flexor after Iliopsoas Tenotomy: Two Case Reports

Raul TORRES-EGUIA ; LE BETANCOURT ; Jesus Mas MARTINEZ ; Javier SANZ-REIG

Hip & Pelvis 2020;32(2):112-117

2.Sequential Hybrid Repair of Aorta and Bilateral Common Iliac Arteries Secondary to Chronic Aortic Dissection with Extensive Aneurysmal Degeneration in a Marfan Patient.

Carlos A HINOJOSA ; Javier E ANAYA-AYALA ; Hugo LAPARRA-ESCARENO ; Rene LIZOLA ; Adriana TORRES-MACHORRO

Vascular Specialist International 2017;33(3):112-116

3.Aortobifemoral Reconstruction with Right Extra-Anatomic Obturator Foramen Bypass due to a Septic Groin.

Carlos A HINOJOSA ; Javier E ANAYA-AYALA ; Hugo LAPARRA-ESCARENO ; Rene LIZOLA ; Adriana TORRES-MACHORRO

Vascular Specialist International 2016;32(2):57-61

4.Tick-borne rickettsial pathogens in questing ticks, removed from humans and animals in Mexico.

Carolina G SOSA-GUTIERREZ ; Margarita VARGAS-SANDOVAL ; Javier TORRES ; Guadalupe GORDILLO-PÉREZ

Journal of Veterinary Science 2016;17(3):353-360

5.Association between Heart Failure and Clinical Prognosis in Patients with Acute Ischemic Stroke: A Retrospective Cohort Study

Jose Luis Lozano VILLANUEVA ; Javier Francisco TORRES ZAFRA ; Fabián Cortés MUÑOZ ; Fernán del Cristo MENDOZA BELTRÁN ; Jenny Carolina Sánchez CASAS ; Luis Alfonso Barragán PEDRAZA

Journal of Clinical Neurology 2021;17(2):200-205

6.Association between Heart Failure and Clinical Prognosis in Patients with Acute Ischemic Stroke: A Retrospective Cohort Study

Jose Luis Lozano VILLANUEVA ; Javier Francisco TORRES ZAFRA ; Fabián Cortés MUÑOZ ; Fernán del Cristo MENDOZA BELTRÁN ; Jenny Carolina Sánchez CASAS ; Luis Alfonso Barragán PEDRAZA

Journal of Clinical Neurology 2021;17(2):200-205

7.Trimethylamine Oxidation into the Proatherogenic Trimethylamine N-Oxide Is Higher in Coronary Heart Disease Men: From the CORDIOPREV Study

Helena GARCIA-FERNANDEZ ; Juan F. ALCALA-DIAZ ; Gracia M. QUINTANA-NAVARRO ; Javier LOPEZ-MORENO ; Diego LUQUE-CORDOBA ; Eugenia Ruiz-Diaz NARVAEZ ; Antonio P. Arenas-de LARRIVA ; Francisco M. GUTIERREZ-MARISCAL ; Jose D. TORRES-PEÑA ; Diego RODRIGUEZ-CANO ; Raul M. LUQUE ; Feliciano PRIEGO-CAPOTE ; Jose LOPEZ-MIRANDA ; Antonio CAMARGO

The World Journal of Men's Health 2025;43(1):249-258

8.Trimethylamine Oxidation into the Proatherogenic Trimethylamine N-Oxide Is Higher in Coronary Heart Disease Men: From the CORDIOPREV Study

Helena GARCIA-FERNANDEZ ; Juan F. ALCALA-DIAZ ; Gracia M. QUINTANA-NAVARRO ; Javier LOPEZ-MORENO ; Diego LUQUE-CORDOBA ; Eugenia Ruiz-Diaz NARVAEZ ; Antonio P. Arenas-de LARRIVA ; Francisco M. GUTIERREZ-MARISCAL ; Jose D. TORRES-PEÑA ; Diego RODRIGUEZ-CANO ; Raul M. LUQUE ; Feliciano PRIEGO-CAPOTE ; Jose LOPEZ-MIRANDA ; Antonio CAMARGO

The World Journal of Men's Health 2025;43(1):249-258

9.Trimethylamine Oxidation into the Proatherogenic Trimethylamine N-Oxide Is Higher in Coronary Heart Disease Men: From the CORDIOPREV Study

Helena GARCIA-FERNANDEZ ; Juan F. ALCALA-DIAZ ; Gracia M. QUINTANA-NAVARRO ; Javier LOPEZ-MORENO ; Diego LUQUE-CORDOBA ; Eugenia Ruiz-Diaz NARVAEZ ; Antonio P. Arenas-de LARRIVA ; Francisco M. GUTIERREZ-MARISCAL ; Jose D. TORRES-PEÑA ; Diego RODRIGUEZ-CANO ; Raul M. LUQUE ; Feliciano PRIEGO-CAPOTE ; Jose LOPEZ-MIRANDA ; Antonio CAMARGO

The World Journal of Men's Health 2025;43(1):249-258

10.Trimethylamine Oxidation into the Proatherogenic Trimethylamine N-Oxide Is Higher in Coronary Heart Disease Men: From the CORDIOPREV Study

Helena GARCIA-FERNANDEZ ; Juan F. ALCALA-DIAZ ; Gracia M. QUINTANA-NAVARRO ; Javier LOPEZ-MORENO ; Diego LUQUE-CORDOBA ; Eugenia Ruiz-Diaz NARVAEZ ; Antonio P. Arenas-de LARRIVA ; Francisco M. GUTIERREZ-MARISCAL ; Jose D. TORRES-PEÑA ; Diego RODRIGUEZ-CANO ; Raul M. LUQUE ; Feliciano PRIEGO-CAPOTE ; Jose LOPEZ-MIRANDA ; Antonio CAMARGO

The World Journal of Men's Health 2025;43(1):249-258

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 14 , 1/2 Show Home Prev Next End page: GO